UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

CURRENT REPORT

Pursuant to Section 13 ORor 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~August~~ 16September 24, 2010

ADVANCE NANOTECH, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-10065	20-1614256
(State or other jurisdiction	(Commission	(I.R.S. Employer
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
of incorporation)	File Number)	Identification No.)

400 Rella Blvd, Suite 160, Montebello, New York, NY		10901
400 Rella Blvd, Suite 160, Montebello, NY		10901
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (212) 583-0080

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~Item 2~~On September 24, 2010, Mr.02 Peter Rugg resigned as a director of the Registrant. ~~Results~~ Mr. Rugg’s resignation was not the result of ~~Operations~~any disagreement between him and ~~Financial~~the ~~Condition~~Registrant on any matter relating to the Registrant’s operations, policies or practices.

Advance Nanotech, Inc. (the “Company”) issued a press release today announcing the Company’s results of operations for the quarter ended June 30, 2010. The press release is attached as Exhibit 99.1 hereto and is incorporated herein in its entirety.

The information included in this Item 2.02 of Current Report on Form 8-K, including the attached Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

d)	Exhibits
Exhibit Number		Description
99.1		Press Release, dated August 16, 2010.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ADVANCE NANOTECH, INC.
	By:	/s/ Jon Buttles
		Name: Jon Buttles Title: Principal Executive Officer
Dated: August 16, 2010

ADVANCE NANOTECH, INC.

2By: /s/ Jon Buttles

~~EXHIBIT~~Name: Jon ~~INDEX~~Buttles

Exhibit No.		Description
99.1		Press Release, dated August 16, 2010 *

Title: Principal Executive Officer

* FurnishedDated: September ~~herewith~~30, 2010

Filing Compare · Advance Nanotech, Inc.